| # | Drug | Count |
|---|---|---|
| 0 | INSULIN HUMAN | 1 |
| 1 | OMALIZUMAB | 1 |
| 2 | PHENOBARBITAL | 1 |
| 3 | ROMIPLOSTIM | 1 |
| 4 | TRICLABENDAZOLE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLABENDAZOLE | 1 | 0.0227 |
| 1 | PHENOBARBITAL | 1 | 0.0001 |
| 2 | ROMIPLOSTIM | 1 | 0.0001 |
| 3 | INSULIN HUMAN | 1 | 0.0000 |
| 4 | OMALIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anthelmintic [EPC] | 1 |
| 1 | Anti-IgE [EPC] | 1 |
| 2 | Insulin [EPC] | 1 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 2 | Insulin [EPC] | 1 | 0.0000 |
| 3 | Anti-IgE [EPC] | 1 | 0.0000 |